Content about Pharmaceutical companies

April 25, 2012
Amgen to buy Turkish drug maker for $700 million

Biotech drug maker Amgen is buying a pharmaceutical company based in Turkey, the companies said Wednesday.

April 25, 2012
Reports: GSK calls $2.6 billion offer for Human Genome Sciences 'full and fair'

GlaxoSmithKline said its offer to buy Human Genome Sciences was "full and fair" Wednesday after HGS turned it down last week, according to published reports.

April 25, 2012
Sun launches generic version of Zyprexa

Sun Pharmaceutical Industries has launched a generic version of a drug used to treat psychiatric disorders, the company said.

April 23, 2012
Watson launches authorized generic diabetes drug

Watson Pharmaceuticals announced the launch of an authorized generic version of a drug used to lower blood glucose in patients with Type 2 diabetes.

April 20, 2012
Bayer donates $25,000 to benefit tornado victims

Bayer on Friday announced that it is providing monetary support for disaster relief efforts through a $25,000 donation from the Bayer USA Foundation to the American Red Cross of southwestern Indiana.

April 20, 2012
FDA approves Bayer blood-glucose monitoring system

Regulators have approved a new blood-glucose monitoring system made by Bayer HealthCare, the company said.

April 20, 2012
Genzyme to present MS drug trials

Drug maker Genzyme plans to present data from trial programs of two multiple sclerosis drugs at the American Academy of Neurology's annual meeting in New Orleans, which starts this Saturday and lasts until next Saturday.

April 17, 2012
Mission, EffRx sign agreement for osteoporosis drug

A U.S. drug maker has made a deal with a Swiss company to manufacture and sell a new osteoporosis treatment in North America.

April 16, 2012
Merck, Endocyte sign deal to develop cancer drug

Two drug makers have signed a deal to develop an experimental drug for treating two types of cancer.

April 13, 2012
Drug makers invested $49.5 billion in R&D in 2011, report finds

Drug companies invested nearly $50 billion in research and development in 2011, according to a new report by a drug industry trade group.

April 11, 2012
Prasco to market authorized generic Vancocin

Prasco Labs will market an authorized generic version of a drug used to treat diarrhea caused by a bacterial infection, the company said Wednesday.

April 11, 2012
Reports: Humira to become top-selling drug this year

Move over, Lipitor: There's a new top drug on the market, according to published reports.

April 11, 2012
Takeda acquires URL Pharma

Takeda Pharmaceutical will acquire privately owned drug maker URL Pharma for $800 million, the companies said Wednesday.

April 9, 2012
FDA approves labeling change for Novo Nordisk diabetes drug

The Food and Drug Administration has approved a change to the label of a Novo Nordisk drug stating that it offers superior blood-sugar control to a competing drug made by Merck, based on results of two clinical studies, Novo Nordisk said Monday.

April 9, 2012
Pfizer brings Lipitor marketing campaign to Walgreens Chicago flagship store

Drug maker Pfizer is taking a marketing campaign for one of its drugs to Walgreens' Chicago flagship store to raise awareness about high cholesterol and healthy eating, the company said Monday.

April 6, 2012
Par launches generic version of Provigil

Par Pharmaceutical has started shipping its generic version of a drug for sleep disorders, the company said Friday.

April 5, 2012
Teva entitled to exclusivity on Provigil, FDA decides

Teva is the first company to file for a generic version of a drug to treat sleep disorders, the Food and Drug Administration has determined.

April 4, 2012
Patents covering Sanctura XR invalid, court rules

A court has ruled that patents covering a drug used for overactive bladder are invalid, a company looking to launch a generic version of the drug said.

April 3, 2012
Prestige Brands completes remainder of GSK OTC brands acquisition

Prestige Brands Holdings on Monday announced that it has completed the purchase of the two remaining brands of the 17 brands it agreed to acquire from GlaxoSmithKline; the purchase of Debrox ear wax remover and Gly-Oxide oral rinse completes the transaction.

April 3, 2012
Watson seeks approval for generic Lumigan, Latisse

Watson is challenging the patent protection on two eye drugs made by Allergan, the generic drug maker said Tuesday.

April 2, 2012
Teva launches generic hypertension drugs

Teva Pharmaceutical Industries has launched generic versions of two blood pressure drugs made by Sanofi, Teva said Monday.

March 30, 2012
Genentech announces results of cancer drug trial

Breast cancer patients taking an experimental drug made by Roche subsidiary Genentech lived significantly longer than those taking another drug made by GlaxoSmithKline, according to results of a late-stage clinical trial.

March 30, 2012
Teva launches authorized generic sleep disorder drug

Teva Pharmaceutical Industries has launched an authorized generic version of Cephalon's Provigil, used for conditions like shift work sleep disorder and narcolepsy, the company said Friday.

March 29, 2012
Kline unveils 2011 drivers of U.S. OTC market

The U.S. over-the-counter drug market saw strong growth in 2011, thanks to switches of prescription drugs to OTC, gains in the allergy relief products category and holistic marketing, according to a new report from Kline.

March 28, 2012
Three generic versions of psychiatric drug launched

Three companies have launched generic versions of a psychiatric drug made by AstraZeneca following a court decision turning down the Anglo-Swedish drug maker's request for an injunction against the Food and Drug Administration's approval of the generics.

© 2013 Drug Store News. All Rights Reserved.